Marks I - Search Results

1

A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder.

Cottraux J, Mollard E, Bouvard M, Marks I, Sluys M, Nury AM, Douge R, Cialdella P. Cottraux J, et al. Among authors: marks i. Int Clin Psychopharmacol. 1990 Jan;5(1):17-30. doi: 10.1097/00004850-199001000-00002. Int Clin Psychopharmacol. 1990. PMID: 2110206 Clinical Trial.

2

Exposure therapy, fluvoxamine, or combination treatment in obsessive-compulsive disorder: one-year followup.

Cottraux J, Mollard E, Bouvard M, Marks I. Cottraux J, et al. Among authors: marks i. Psychiatry Res. 1993 Oct;49(1):63-75. doi: 10.1016/0165-1781(93)90030-k. Psychiatry Res. 1993. PMID: 8140182 Clinical Trial.

3

Clomipramine in obsessive-compulsive ritualisers treated with exposure therapy: relations between dose, plasma levels, outcome and side effects.

Kasvikis Y, Marks IM. Kasvikis Y, et al. Among authors: marks im. Psychopharmacology (Berl). 1988;95(1):113-8. doi: 10.1007/BF00212778. Psychopharmacology (Berl). 1988. PMID: 3133689 Clinical Trial.

4

Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder.

O'Sullivan G, Noshirvani H, Marks I, Monteiro W, Lelliott P. O'Sullivan G, et al. Among authors: marks i. J Clin Psychiatry. 1991 Apr;52(4):150-5. J Clin Psychiatry. 1991. PMID: 2016246 Clinical Trial.

5

Home self-assessment and self-treatment of obsessive-compulsive disorder using a manual and a computer-conducted telephone interview: replication of a UK-US study.

Bachofen M, Nakagawa A, Marks IM, Park JM, Greist JH, Baer L, Wenzel KW, Parkin JR, Dottl SL. Bachofen M, et al. Among authors: marks im. J Clin Psychiatry. 1999 Aug;60(8):545-9. doi: 10.4088/jcp.v60n0807. J Clin Psychiatry. 1999. PMID: 10485637

6

The 'efficacy' of alprazolam in panic disorder and agoraphobia: a critique of recent reports.

Marks IM, De Albuquerque A, Cottraux J, Gentil V, Greist J, Hand I, Liberman RL, Relvas JS, Tobeña A, Tyrer P, et al. Marks IM, et al. Arch Gen Psychiatry. 1989 Jul;46(7):668-72. doi: 10.1001/archpsyc.1989.01810070094015. Arch Gen Psychiatry. 1989. PMID: 2660772 Clinical Trial. No abstract available.

7

Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control.

Greist JH, Marks IM, Baer L, Kobak KA, Wenzel KW, Hirsch MJ, Mantle JM, Clary CM. Greist JH, et al. J Clin Psychiatry. 2002 Feb;63(2):138-45. doi: 10.4088/jcp.v63n0209. J Clin Psychiatry. 2002. PMID: 11874215 Clinical Trial.

8

Obsessive-compulsive disorder: case study and discussion of treatment.

Turk J, Marks IM, Horder J. Turk J, et al. Among authors: marks im. Br J Gen Pract. 1990 May;40(334):210-2. Br J Gen Pract. 1990. PMID: 2114137 Free PMC article.

9

Clomipramine, self-exposure and therapist-aided exposure for obsessive-compulsive rituals.

Marks IM, Lelliott P, Basoglu M, Noshirvani H, Monteiro W, Cohen D, Kasvikis Y. Marks IM, et al. Br J Psychiatry. 1988 Apr;152:522-34. doi: 10.1192/bjp.152.4.522. Br J Psychiatry. 1988. PMID: 3167404 Clinical Trial.

10

[Behavior psychotherapy in obsessive-compulsive disorders].

Marks IM. Marks IM. Encephale. 1990 Jul-Aug;16 Spec No:341-6. Encephale. 1990. PMID: 2209493 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

658 results

Search Page

Filters